Pharmather Holdings Stock Investor Sentiment

PHRRF Stock  USD 0.17  0.01  5.56%   
Roughly 62% of Pharmather Holdings' investor base is looking to short. The analysis of current outlook of investing in Pharmather Holdings suggests that many traders are alarmed regarding Pharmather Holdings' prospects. The current market sentiment, together with Pharmather Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Pharmather Holdings stock news signals to limit their universe of possible portfolio assets.
Pharmather Holdings otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharmather daily returns and investor perception about the current price of Pharmather Holdings as well as its diversification or hedging effects on your existing portfolios.
  
over a week ago at news.google.com         
PharmaTher Updates on FDA Ketamine Application - TipRanks
Google News at Macroaxis
over two weeks ago at news.google.com         
PharmaTher granted post-CRL clarification meeting request by FDA - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
TSX Penny Stocks To Consider In October 2024 - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
TSX Energy Capped Index Quote - Press Release - The Globe and Mail
Google News at Macroaxis
over three months ago at news.google.com         
SP 500 Health Care Sector Quote - Press Release - The Globe and Mail
Google News at Macroaxis
over three months ago at news.google.com         
PharmaThers Potential Breakthrough in Monkeypox Treatment - TipRanks
Google News at Macroaxis
over three months ago at news.google.com         
PharmaThers Sairiyo Advances with Clinical Trial Approval - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaThers Novel Ketamine Heads For The US Market With New Collaboration Agreement - MSN
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Advances Clinical Trials for New Treatment - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher announces assigned GDUFA goal data for Ketamine ANDA - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Advances Cepharanthine Phase 1 Trials - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Optimistic on Resolving Ketamine Shortage - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Closer to Resolving US Ketamine Shortage - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaThers Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cephara...
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine - ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharmather Holdings that are available to investors today. That information is available publicly through Pharmather media outlets and privately through word of mouth or via Pharmather internal channels. However, regardless of the origin, that massive amount of Pharmather data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharmather Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharmather Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharmather Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharmather Holdings alpha.

Pharmather Holdings Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharmather OTC Stock analysis

When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas